InvestSMART

Neuren Pharmaceuticals Limited (ASX: NEU) - Announcements

Current share price for NEU : $17.470 0.78 (4.67%)+

ASX company news and announcements for Neuren Pharmaceuticals Limited (NEU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neuren Pharmaceuticals Limited (NEU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neuren Pharmaceuticals Limited (NEU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neuren Pharmaceuticals Limited (NEU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,213 Update - Notification of buy-back - NEU 20 May 2025 8:26AM $12.630 $17.460 risen by 38.24%
$2,213 Update - Notification of buy-back - NEU 19 May 2025 8:52AM $13.190 $17.460 risen by 32.37%
$2,213 Update - Notification of buy-back - NEU 16 May 2025 9:11AM $12.960 $17.460 risen by 34.72%
$2,213 Update - Notification of buy-back - NEU 15 May 2025 8:00AM $13.180 $17.460 risen by 32.47%
$2,213 Update - Notification of buy-back - NEU 14 May 2025 8:20AM $12.330 $17.460 risen by 41.61%
$2,213 NEU receives FDA minutes and re-confirms Phase 3 endpoints 13 May 2025 2:06PM $12.385 $17.460 risen by 40.98%
$2,213 Update - Notification of buy-back - NEU 13 May 2025 9:04AM $12.020 $17.460 risen by 45.26%
$2,213 Update - Notification of buy-back - NEU 12 May 2025 9:09AM $13.290 $17.460 risen by 31.38%
$2,213 Update - Notification of buy-back - NEU 9 May 2025 7:30AM $12.800 $17.460 risen by 36.41%
$2,213 Update - Notification of buy-back - NEU 8 May 2025 9:08AM $12.620 $17.460 risen by 38.35%
$2,213 DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024 8 May 2025 9:02AM $12.620 $17.460 risen by 38.35%
$2,213 Update - Notification of buy-back - NEU 7 May 2025 7:31AM $12.150 $17.460 risen by 43.70%
$2,213 Notification of cessation of securities - NEU 6 May 2025 8:51AM $12.300 $17.460 risen by 41.95%
$2,213 Update - Notification of buy-back - NEU 6 May 2025 8:50AM $12.300 $17.460 risen by 41.95%
$2,213 Becoming a substantial holder 5 May 2025 6:31PM $12.300 $17.460 risen by 41.95%
$2,213 Update - Notification of buy-back - NEU 5 May 2025 9:14AM $12.440 $17.460 risen by 40.35%
$2,213 Neuren appoints Daryl DeKarske to executive team 2 May 2025 9:09AM $11.800 $17.460 risen by 47.97%
$2,213 Update - Notification of buy-back - NEU 2 May 2025 8:09AM $11.800 $17.460 risen by 47.97%
$2,213 Update - Notification of buy-back - NEU 1 May 2025 8:53AM $11.660 $17.460 risen by 49.74%
$2,213 Update - Notification of buy-back - NEU 30 Apr 2025 7:55AM $11.560 $17.460 risen by 51.04%
$2,213 Update - Notification of buy-back - NEU 29 Apr 2025 7:33AM $10.990 $17.460 risen by 58.87%
$2,213 Update - Notification of buy-back - NEU 28 Apr 2025 9:08AM $11.340 $17.460 risen by 53.97%
$2,213 Virtual AGM online guide 24 Apr 2025 9:26AM $11.010 $17.460 risen by 58.58%
$2,213 Notice of Annual General Meeting/Proxy Form 24 Apr 2025 9:20AM $11.010 $17.460 risen by 58.58%
$2,213 Update - Notification of buy-back - NEU 24 Apr 2025 8:53AM $11.010 $17.460 risen by 58.58%

101 - 125 of 821 results

Page 5 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.